Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Deedwania

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Journal of the American College of Cardiology|January 24, 2015
Gaps in guideline implementation: a cause for concern, time for actionPrakash Deedwania
Annals of Internal Medicine|August 17, 2011
ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetesPrakash Deedwania
International Journal of Cardiology|August 22, 2008
The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolismPrakash Deedwania
Drugs|September 26, 2013
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failurePrakash Deedwania
Postgraduate Medicine|October 6, 2005
Avoid the rush to judgment in acute coronary syndromesPrakash Deedwania
Drugs of Today (Barcelona, Spain : 1998)|July 4, 2008
Expanding roles for atorvastatinVibhuti Singh, Prakash Deedwania
Cardiology Clinics|January 25, 2011
Interventions for cardiovascular disease preventionRajeev Gupta, Prakash Deedwania
Journal of the American College of Cardiology|February 18, 2017
Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?Prakash Deedwania, Tushar Acharya
Journal of the American College of Cardiology|October 7, 2017
Hearty Breakfast for Healthier ArteriesPrakash Deedwania, Tushar Acharya
Cardiology Clinics|February 8, 2005
Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approachSundararajan Srikanth, Prakash Deedwania
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|January 24, 2015
Gaps in guideline implementation: a cause for concern, time for actionPrakash Deedwania
Annals of Internal Medicine|August 17, 2011
ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetesPrakash Deedwania
International Journal of Cardiology|August 22, 2008
The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolismPrakash Deedwania
Drugs|September 26, 2013
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failurePrakash Deedwania
Postgraduate Medicine|October 6, 2005
Avoid the rush to judgment in acute coronary syndromesPrakash Deedwania
Drugs of Today (Barcelona, Spain : 1998)|July 4, 2008
Expanding roles for atorvastatinVibhuti Singh, Prakash Deedwania
Cardiology Clinics|January 25, 2011
Interventions for cardiovascular disease preventionRajeev Gupta, Prakash Deedwania
Journal of the American College of Cardiology|February 18, 2017
Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?Prakash Deedwania, Tushar Acharya
Journal of the American College of Cardiology|October 7, 2017
Hearty Breakfast for Healthier ArteriesPrakash Deedwania, Tushar Acharya
Cardiology Clinics|February 8, 2005
Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approachSundararajan Srikanth, Prakash Deedwania
Pageof 19